PATENT CLAIM ANALYSIS

Application Number: 16331920
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "261100"]

Abstract:
Triazolo(4,5-d)pyrimidine derivatives for use in treatment or prevention of bacterial infection in a host mammal in need of such treatment or use as inhibitor of biofilm formation on a surface of biomaterial or medical device, particularly of cardiovascular device such as prosthetic heart valve or pacemakers.

Claim (Index 16):
The method for treatment according to  claim 15 , wherein the Triazolo(4,5-d)pyrimidine derivative is (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol) or Triafluocyl.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 99.0
- Lexical Diversity: 1.40541
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11841030', '11980907', '11981071', '14958619', '16025170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.756223155974948
- 35 USC 102 Novelty (BERT): 0.5210694941563241
- Combined Prediction Score: 0.7327077897930857
- Mean Citation Score: 263.689836
- Max Citation Score: 313.5044
- Similarity Product: 268.0138098445653

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test